ATOSSA THERAPEUTICS INC's ticker is ATOS and the CUSIP is 04962H506. A total of 14 filers reported holding ATOSSA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.81 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,753 | -53.9% | 13,233 | -21.2% | 0.00% | -100.0% |
| Q2 2023 | $21,148 | +264250.0% | 16,784 | +61.4% | 0.00% | – |
| Q1 2023 | $8 | +300.0% | 10,400 | +196.2% | 0.00% | – |
| Q4 2022 | $2 | – | 3,511 | +8065.1% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 43 | -96.8% | 0.00% | – |
| Q2 2022 | $1,000 | -96.9% | 1,351 | -94.7% | 0.00% | – |
| Q1 2022 | $32,000 | -11.1% | 25,391 | +13.6% | 0.00% | -100.0% |
| Q4 2021 | $36,000 | +50.0% | 22,360 | +195.6% | 0.00% | 0.0% |
| Q3 2021 | $24,000 | -20.0% | 7,564 | +58.0% | 0.00% | 0.0% |
| Q2 2021 | $30,000 | +900.0% | 4,787 | +292.4% | 0.00% | – |
| Q3 2020 | $3,000 | -50.0% | 1,220 | -27.2% | 0.00% | – |
| Q2 2020 | $6,000 | 0.0% | 1,676 | -25.5% | 0.00% | – |
| Q2 2019 | $6,000 | – | 2,250 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GSA CAPITAL PARTNERS LLP | 347,392 | $256 | 0.02% |
| XTX Topco Ltd | 167,427 | $123,310 | 0.02% |
| Laurion Capital Management LP | 2,225,800 | $1,639,302 | 0.01% |
| Virtu Financial LLC | 80,728 | $59 | 0.01% |
| Renaissance Technologies | 1,242,370 | $915 | 0.00% |
| LVM CAPITAL MANAGEMENT LTD/MI | 21,000 | $15 | 0.00% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 50,000 | $36,825 | 0.00% |
| Connor, Clark & Lunn Investment Management Ltd. | 133,591 | $98,390 | 0.00% |
| Caption Management, LLC | 75,000 | $55,238 | 0.00% |
| J. L. Bainbridge & Co., Inc. | 11,121 | $8,191 | 0.00% |